Pharmacotherapeutics of SARS-CoV-2

Pharmacotherapeutics of SARS-CoV-2

Bibliographic Details
Main Authors:	Harish Gupta, Nitu Nigam, Satish Kumar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Journal of Family Medicine and Primary Care
Online Access:	http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=8;spage=4892;epage=4893;aulast=Gupta

Similar Items

Unfolding issues of immunity against SARS-CoV-2
by: Harish Gupta, et al.
Published: (2022-01-01)

Routes of transmission of SARS-CoV-2
by: Harish Gupta, et al.
Published: (2022-01-01)

Evolving pharmacotherapeutics for the Covid-19 pandemic
by: Harish Gupta
Published: (2022-01-01)

Wise investment is needed for maximising the benefits in Covid times
by: Harish Gupta, et al.
Published: (2022-01-01)

Business without ethics is good for none
by: Harish Gupta, et al.
Published: (2022-01-01)

Diagnostic Tools for Rapid Screening and Detection of SARS-CoV-2 Infection
by: Satish Kumar Pandey, et al.
Published: (2022-07-01)

On inequality of gender relationship and its effect on pregnancy outcomes
by: Harish Gupta, et al.
Published: (2022-01-01)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
by: Rajat Goyal, et al.
Published: (2022-09-01)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
by: Taniya Bhardwaj, et al.
Published: (2023-02-01)

Good education and communication can change the world
by: Harish Gupta, et al.
Published: (2022-01-01)

Does gender-equality concern with non-communicable diseases in India?
by: Harish Gupta, et al.
Published: (2023-10-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

SARS-CoV-2 Variants and Vaccine Boosters
by: Rajeev Gupta
Published: (2023-07-01)

Children’s SARS-CoV-2 Infection and Their Vaccination
by: Sneh Lata Gupta, et al.
Published: (2023-02-01)

The Comparison of SARS-CoV-2, SARS-CoV, and MERS-CoV Genome and Spike Protein Variations
by: Choirun Nita Fikriani, et al.
Published: (2021-03-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)

Performance comparison between Elecsys Anti-SARS-CoV-2 and Anti-SARS-CoV-2 S and Atellica IM SARS-CoV-2 Total and SARS-CoV-2 IgG assays
by: Seri Jeong, et al.
Published: (2022-06-01)

Analysis of SARS-CoV-2 genome evolutionary patterns
by: Shubhangi Gupta, et al.
Published: (2024-02-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

An Exploration of Nanoparticle-Based Diagnostic Approaches for Coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Ahmed Al-Hindawi, et al.
Published: (2022-10-01)

An update on SARS-CoV-2 immunization and future directions
by: Rashmi Rana, et al.
Published: (2023-03-01)

Impact of Antenatal SARS-CoV-2 Exposure on SARS-CoV-2 Neutralization Potency
by: Chia-Jung Chiang, et al.
Published: (2024-02-01)

Sequence similarity of SARS-CoV-2 and humans: Implications for SARS-CoV-2 detection
by: Heng Li, et al.
Published: (2022-07-01)

Mitochondrial Pharmacotherapeutics - Advancements and Applications
by: Vyas Ganesh, et al.
Published: (2024-01-01)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
by: Kim, KS, et al.
Published: (2021)

The evolution of SARS-CoV-2
by: Markov, PV, et al.
Published: (2023)

Immunouniverse of SARS-CoV-2
by: Dennis Jiménez, et al.
Published: (2022-10-01)

Superantigens and SARS-CoV-2
by: Adam Hamdy, et al.
Published: (2022-03-01)

Taking on SARS-CoV-2
by: Paola Kučan Brlić, et al.
Published: (2022-06-01)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
by: Ma’mon M. Hatmal, et al.
Published: (2020-12-01)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021-01-01)

Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63
by: Darina Bačenková, et al.
Published: (2021-02-01)

Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
by: Kwang-Soo Lyoo, et al.
Published: (2023-02-01)

Does SARS-CoV-2 bind to human ACE2 stronger than SARS-CoV?
by: Nguyen, HL, et al.
Published: (2020)

Unique tRNA Fragment Upregulation with SARS-CoV-2 but Not with SARS-CoV Infection
by: Isabella Imirowicz, et al.
Published: (2023-12-01)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
by: Huibin Lv, et al.
Published: (2020-06-01)

Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy
by: Annalisa D’Arco, et al.
Published: (2023-05-01)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
by: Mitsuru Sada, et al.
Published: (2020-10-01)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023-06-01)